We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$82.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
1 quarter
Avg Time Held Equity only
4.4 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
1 quarter

Top Buys

Rank Stock Value
1
JNPR icon
Juniper Networks
JNPR
+$162M
2
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS icon
Ansys
ANSS
+$119M
4
X icon
US Steel
X
+$104M
5
CTLT icon
CATALENT, INC.
CTLT
+$93.3M

Top Sells

Rank Stock Value
1
SPLK icon
Splunk Inc
SPLK
+$561M
2
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$120M
3
IMGN icon
Immunogen Inc
IMGN
+$56.8M
4
CPRI icon
Capri Holdings
CPRI
+$44.2M
5
PXD icon
Pioneer Natural Resource Co.
PXD
+$34M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Miscellaneous 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NNN icon
326
NNN REIT
NNN
$7.71B
$457K 0.01%
10,700
-95,222
-90% -$3.96M
2021 Q4
9 quarters
THRD icon
327
DELISTED
Third Harmonic Bio
THRD
$457K 0.01%
48,403
-16,301
-25% -$158K
2023 Q3
2 quarters
PTCT icon
328
PTC Therapeutics
PTCT
$5.39B
$436K 0.01%
15,000
-21,052
-58% -$590K
2022 Q4
5 quarters
SVRA icon
329
Savara
SVRA
$992M
$435K 0.01%
87,437
-89,449
-51% -$432K
2022 Q2
7 quarters
CPT icon
330
Camden Property Trust
CPT
$11.2B
$431K 0.01%
4,375
-2,648
-38% -$256K
2022 Q2
7 quarters
NHI icon
331
National Health Investors
NHI
$3.17B
$426K 0.01%
6,775
-51,375
-88% -$2.9M
2022 Q2
7 quarters
ETNB icon
332
DELISTED
89bio
ETNB
$419K 0.01%
35,962
-43,113
-55% -$477K
2022 Q3
6 quarters
PCVX icon
333
Vaxcyte
PCVX
$11B
$410K 0.01%
6,007
-2,023
-25% -$140K
2023 Q3
2 quarters
CNTX icon
334
Context Therapeutics
CNTX
$27.9M
$409K 0.01%
296,675
– –
2023 Q2
3 quarters
LYV icon
335
PUT
Live Nation Entertainment
LYV
$39.3B
$409K 0.01%
237,900
+8,400
+4% +$794K
2023 Q3
2 quarters
AMC icon
336
AMC Entertainment Holdings
AMC
$2.6B
$401K 0.01%
107,755
-2,014
-2% -$8.97K
2023 Q3
2 quarters
PANW icon
337
Palo Alto Networks
PANW
$336B
$398K 0.01%
2,800
-17,200
-86% -$2.71M
2023 Q3
2 quarters
NCLH icon
338
PUT
Norwegian Cruise Line
NCLH
$6.92B
$396K 0.01%
233,800
+178,700
+324% +$3.25M
2021 Q2
11 quarters
QTRX icon
339
Quanterix
QTRX
$150M
$396K 0.01%
16,794
– –
2023 Q2
3 quarters
VKTX icon
340
CALL
Viking Therapeutics
VKTX
$3.57B
$388K 0.01%
+50,000
New +$2.22M
2024 Q1
0 quarters
ESPR icon
341
DELISTED
Esperion Therapeutics
ESPR
$382K 0.01%
142,418
-384,705
-73% -$935K
2022 Q3
6 quarters
SKIL icon
342
Skillsoft
SKIL
$55.4M
$375K 0.01%
41,692
+11
+0% +$139
2023 Q4
1 quarter
QURE icon
343
uniQure
QURE
$1.53B
$370K 0.01%
71,064
-23,936
-25% -$137K
2022 Q4
5 quarters
HLF icon
344
PUT
Herbalife
HLF
$1.36B
$358K 0.01%
+82,400
New +$886K
2024 Q1
0 quarters
NVCR icon
345
NovoCure
NVCR
$1.67B
$356K 0.01%
+22,782
New +$335K
2024 Q1
0 quarters
UTHR icon
346
United Therapeutics
UTHR
$23.6B
$351K 0.01%
1,528
-3,515
-70% -$793K
2022 Q1
8 quarters
CSR icon
347
Centerspace
CSR
$924M
$346K 0.01%
+6,050
New +$337K
2024 Q1
0 quarters
TRML icon
348
PUT
DELISTED
Tourmaline Bio
TRML
$345K 0.01%
+20,000
New +$705K
2024 Q1
0 quarters
XENE icon
349
Xenon Pharmaceuticals
XENE
$3.51B
$344K 0.01%
7,987
-6,689
-46% -$308K
2022 Q1
8 quarters
WIX icon
350
WIX.com
WIX
$3.15B
$344K 0.01%
2,500
-30,900
-93% -$4.07M
2023 Q4
1 quarter
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.